Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 6/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | GSK3A | P49840 | 2/20 | 0.41 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.41 |
| ▸ | KRAS | P01116 | 8/20 | 0.40 |
| ▸ | TGM2 | P21980 | 1/20 | 0.40 |
| ▸ | PNP | P00491 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16003047 | 0.83 | HINT1 (0.42) | HINT1TAAR1GSK3ARPS6KA3MAPK14 | |
| SCHEMBL16480535 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL16480522 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL15588433 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL16480891 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL15588434 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL15588437 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL16480516 | 0.80 | CYP3A4 (0.58) | HINT1TAAR1KRASTGM2NT5E | |
| SCHEMBL23171224 | 0.80 | HINT1 (0.51) | HINT1GSK3ARPS6KA3MAPK14KRAS | |
| SCHEMBL23348772 | 0.80 | HINT1 (0.48) | HINT1TAAR1GSK3ARPS6KA3MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2906579-B1 | 2'-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION | IDENIX PHARMACEUTICALS LLC (US) | 2018-04-18 | — | — | EP | disclosed |